Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035515
Filing Date
2020-08-03
Accepted
2020-08-03 16:15:45
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arav-10q_20200630.htm 10-Q 1425875
2 EX-31.1 arav-ex311_9.htm EX-31.1 17354
3 EX-31.2 arav-ex312_6.htm EX-31.2 17169
4 EX-32.1 arav-ex321_7.htm EX-32.1 7798
5 EX-32.2 arav-ex322_8.htm EX-32.2 7670
  Complete submission text file 0001564590-20-035515.txt   4809852

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arav-20200630.xml EX-101.INS 932606
7 XBRL TAXONOMY EXTENSION SCHEMA arav-20200630.xsd EX-101.SCH 36153
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20200630_cal.xml EX-101.CAL 36068
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20200630_def.xml EX-101.DEF 93874
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20200630_lab.xml EX-101.LAB 304755
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20200630_pre.xml EX-101.PRE 220326
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 201069412
SIC: 2834 Pharmaceutical Preparations